Developer docs
API playgroundTry for free, no card

Search company profiles

Novelab

Full company profile

uuid002ervq

Namestring
Novelab
Legal namestring
NOVELAB S.E.L.A.S.
Websiteurl
novelab.fr
Company typeenum
Private
Founded yearint
2011
Descriptiontext

Novelab is a France-based multi-site medical biology laboratory group operating 24 physical laboratory sites across the Lyon periphery, the Ain department, and the Mâconnais region in southeast France. Founded in its current form in 2011 through the fusion of several legacy entities (dating back to 2005), the group is structured as a SELAS (Société d'Exercice Libéral par Actions Simplifiée) and is collectively owned by independent liberal biologists — both physicians and pharmacists — affiliated with the Groupement des Laboratoires de Biologie Indépendante (LBI). Novelab employs 150+ staff including biologists, qualified technicians, nurses, couriers, and support personnel, and conducts the vast majority of routine medical biology analyses in-house, outsourcing approximately 2% of specialized volume to Eurofins-Biomnis and the Établissement Français du Sang (EFS).

The group's service portfolio is anchored by routine NABM-reimbursed analyses (blood draws, urine tests, screenings) under the French Sécurité Sociale framework, complemented by specialized reproductive biology services (spermogram, TMS, spermoculture, MAR test, IAC/IUU intrauterine insemination) at three PMA-approved sites, as well as PCR COVID testing and a growing catalog of out-of-pocket sans-ordonnance panels (check-up €50, metabolic €45, fatigue €60, hormonal €42, STI panel). Technology infrastructure centers on ISO 15189 V2022 quality management, the MyKali secure online results portal, Doctolib appointment booking for specialized tests, and Identité Nationale de Santé (INS) identity verification, with ongoing lab-process automation investments such as the Beckman DxA chain at the Grand Laboratoire d'Ambérieu.

Commercially, Novelab pursues a hybrid direct-to-consumer and sales-led GTM: patients walk in without appointment at most sites Monday through Saturday, while a parallel referral-driven channel pulls volume from prescribing physicians, gynecologists, polyclinics, nursing homes, and liberal nurses operating in the territory. Recent geographic expansion (Charvieu-Chavagneux September 2025, Saint-Maurice-de-Beynost February 2026) and a sustained M&A track record (eight acquisitions or fusions since 2012) demonstrate a controlled roll-up strategy, while growing participation in CPTS (Communautés Professionnelles Territoriales de Santé) and urgent-care health centers signals increasing integration into the regional primary-care ecosystem.

Short descriptiontext

Novelab is a French multi-site medical biology laboratory group operating 24 walk-in laboratory sites across the Lyon periphery, Ain, and Mâconnais regions, serving individual patients, referring physicians, clinics, and nursing homes with NABM-reimbursed analyses, specialized reproductive biology, and out-of-pocket screening panels under ISO 15189 V2022 quality standards.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersCorcelles-en-beaujolais, France
HQ citystring
Corcelles-en-beaujolais
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices24 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical biology laboratory, diagnostic testing services, clinical pathology analysis, reproductive biology services, health screening packages
Industry1 code
PRIMARYHLAFAMAB
Clinical Chemistry & Immunoassay Laboratories
NAICS code2 codes
  • Medical and Diagnostic Laboratories6215
  • Medical Laboratories621511
SIC code1 code
  • Services-Medical Laboratories8071
Product category
Medical Laboratory Services
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Medical Biology Analyses (NABM Reimbursement)
TypeSubscription Recurring
Description

The majority of revenue is generated through reimbursable medical biology analyses billed under the Nomenclature des Actes de Biologie Médicale (NABM) to the French national health insurance (Sécurité Sociale). Prices are regulated and periodically reduced by the Assurance Maladie. Some analyses are classified hors nomenclature (HN) and charged additionally to the patient.

novelab.fr
2Out-of-Pocket Tests (Sans Ordonnance)
TypeOne Time License
Description

Novelab offers certain tests without a prescription at fixed patient-paid prices (e.g., check-up package €50, beta-HCG pregnancy test €20, glycemia €16, ECBU €20, metabolic panel €45, fatigue panel €60, hormonal panel €42). These are paid directly by patients.

novelab.fr
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain
Pricing details7 tiers
1Check-up package (Bilan Check-up)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

€50 for the full check-up panel including NFS, ferritin, TSH, creatinine/eGFR, Na+/K+, transaminases/GGT, CRP, glycemia, lipid profile, uric acid, calcium, vitamin D

novelab.fr
2Beta-HCG pregnancy test (sans ordonnance)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

€20 per test

novelab.fr
3Glycemia (diabetes screening, sans ordonnance)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

€16 per test

novelab.fr
4ECBU - urinary infection screening (sans ordonnance)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

€20 per test

novelab.fr
5Metabolic panel - diabetes and cardiovascular risk (sans ordonnance)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

€45 for metabolic panel including glycemia, insulin/HOMA/QUICKI, lipid profile, uric acid, creatinine/eGFR, Na+/K+

novelab.fr
6Fatigue panel (sans ordonnance)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

€60 for fatigue panel including NFS, ferritin, glycemia, transaminases, CRP, Na+/K+, vitamin D, folate B9, vitamin B12, calcium, magnesium

novelab.fr
7Hormonal panel - menopause assessment (sans ordonnance)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

€42 for FSH and estradiol dosage

novelab.fr
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Novelab operates 24 medical biology laboratories across the Lyon periphery, Ain, and M\u00e2connais regions of France, performing routine medical biology analyses (blood draws, urine tests, microbiology) primarily reimbursed through the French national health insurance under NABM. The group offers specialized reproductive biology services (spermogram, spermoculture, intrauterine insemination) at three dedicated sites, PCR COVID testing, and self-paid health check-up packages without prescription. Patients access services via walk-in (no appointment required for most blood draws), Doctolib online booking for specialized tests, and retrieve results via the MyKali online portal.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Novelab is a multi-site medical biology laboratory group consisting of 24 laboratory sites across the Lyon periphery, Ain, and Mâcon regions. The company offers a unified platform of services anchored by routine medical biology analyses (blood tests, urine tests) performed across all sites, complemented by specialized reproductive biology services including spermogram/TMS and intrauterine insemination (IUU/IAC) at designated locations. Additional offerings include PCR COVID testing, IST screening, and various health check-up packages available without prescription. Patients access results through an online portal and can book appointments via Doctolib. Specialized analyses (2% of volume) are outsourced to partners EUROFINS-BIOMNIS and EFS.

Product and service13 records
1Routine Medical Biology Analyses
CategoryRoutine medical biology analyses
Description

Comprehensive range of routine medical biology tests including blood draws, urine tests, and other analyses performed across all 24 Novelab laboratory sites. Available to patients both with and without physician prescription, with most tests reimbursed under the French NABM nomenclature.

2Spermiology Services
CategoryReproductive biology analyses
Description

Specialized reproductive biology services including spermogram, test de migration-survie (TMS), spermoculture, MAR test, and sperm DNA fragmentation analysis, available by appointment at designated Novelab sites.

3Intrauterine Insemination (IUI/IAC)
CategoryAssisted reproductive technology
Description

Intrauterine insemination (IUU/IAC) with approved biologists for sperm analysis, preparation, and insemination support at dedicated Novelab sites. Up to 6 covered attempts available per French social security reimbursement rules.

4Test Post Coital (TPC/Huhner)
CategoryReproductive biology analyses
Description

Post-coital cervical mucus test performed during the pre-ovulatory period to evaluate cervical mucus permeability to spermatozoa, available at three designated Novelab sites.

5PCR COVID Testing
CategoryPolymerase chain reaction testing
Description

COVID-19 PCR testing available with or without appointments depending on symptomatic status, with result reporting to the SIDEP national database, performed at multiple Novelab laboratory sites including Villefranche-sur-Sa\u00f4ne.

6IST Screening (Mon Test IST)
CategorySelf-paid screening packages
Description

Comprehensive sexually transmitted infection screening package covering HIV, Hepatitis B, Hepatitis C, Syphilis, Chlamydia, and Gonorrhea, available without prescription and fully covered for under-26 patients under French social security.

7Bilan Check-up (Complete Check-up Package)
CategorySelf-paid screening packages
Description

Full check-up screening panel priced at €50 covering complete blood count, ferritin, TSH, kidney function, electrolytes, liver enzymes, CRP, glycemia, full lipid profile, uric acid, calcium, and vitamin D, available without a prescription.

8Bilan Fatigue (Fatigue Panel)
CategorySelf-paid screening packages
Description

Fatigue assessment panel including NFS, ferritin, glycemia, transaminases, CRP, electrolytes, vitamin D, folate B9, vitamin B12, calcium, and magnesium, priced at €60 without prescription.

9Bilan M\u00e9tabolique (Metabolic/Diabetes-Cardiovascular Panel)
CategorySelf-paid screening packages
Description

Metabolic and cardiovascular risk screening covering glycemia, insulin/HOMA/QUICKI, lipid profile, uric acid, kidney function, and electrolytes, priced at €45 without prescription.

10Bilan Hormonal (Menopause Hormonal Panel)
CategorySelf-paid screening packages
Description

Hormonal panel measuring FSH and estradiol for menopause assessment, priced at €42 without prescription.

11ECBU (Cytobacteriological Urine Examination)
CategorySelf-paid screening packages
Description

Cytobacteriological examination of urine for diagnosing urinary tract infections, priced at €20 without prescription.

12Beta-hCG Pregnancy Test
CategorySelf-paid screening packages
Description

Blood-based pregnancy testing via beta-hCG hormone dosage, priced at €20 without prescription.

13MyKali Online Results Portal
CategoryPatient digital services
Description

Patient-facing web portal for securely accessing test results online via email notification, providing permanent password access for 180 days for result retrieval.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
1Colloquium en Calade - Reproductive Biology Partners
Strategic tierMinorTypeGTM or Marketing PartnerAnnounced on2023-11-17
Description

Annual scientific colloquium on infertility held in the Beaujolais region. Partners include: Theradiag, IBSA France, Organon France, Eugin, Ferring Pharmaceuticals France, Merck, Theramex, Gedeon Richter France, Institut Marquès, Barcelona IVF, EFFIK. Novelab is a sponsoring partner.

novelab.fr
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Eurofins-Biomnis is a specialized medical biology laboratory providing reference analyses not performed in-house. Novelab refers approximately 2% of its analysis volume to Eurofins-Biomnis for specialized testing.

3EFS (Établissement Français du Sang)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

The French Blood Establishment provides specialized blood banking and transfusion-related analyses. Novelab partners with EFS for the 2% of specialized volume that requires external laboratory services.

novelab.fr
Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1Doctolib
TypeOthers
Description

Not a lab but a critical ecosystem partner integrated by Novelab for online appointment booking. Listed as OTHERS because it is an enabling technology platform that channels patient demand to Novelab's specialized services rather than a direct lab competitor.

2Unilabs
TypeBroad incumbent
Description

European diagnostics provider with French operations covering routine and specialty medical biology. Comparable as a multi-site medical laboratory serving physicians, clinics, and patients across regions of France.

TypeBroad incumbent
Description

Major pan-European medical diagnostics provider with a significant French laboratory footprint. Comparable as a multi-site routine and specialized medical biology operator serving physicians, clinics, and patients across regional France.

TypeBroad incumbent
Description

French medical biology network consolidating independent labs nationally. Closely comparable in business model (multi-site routine biology + specialty) and explicitly competes for the same independent-lab consolidation pipeline as Novelab.

TypeBroad incumbent
Description

Specialized reference laboratory partner to which Novelab outsources 2% of its volume. Directly comparable as a French medical biology testing provider, with a much broader specialty test menu and national footprint.

TypeBroad incumbent
Description

One of the largest French/European medical biology networks, offering routine and specialized lab services. Comparable as a multi-site laboratory group serving French clinicians, though at significantly larger scale and broader geographic reach than Novelab.

TypeRegional player
Description

Regional French medical biology laboratory network offering routine analyses with multi-site presence. Comparable as a French regional multi-site laboratory group with similar NABM-reimbursed business model, though not necessarily overlapping Novelab's Lyon/Ain/Mâconnais territory.

8Laboratoire de Biologie Médicale (LBI Groupement)
TypeDirect peer
Description

Umbrella organization of independent French medical biologists of which Novelab is a member. Comparable as a federation of independent regional lab groups adhering to similar operating, quality, and governance models.

TypeBroad incumbent
Description

Specialized French medical biology lab offering routine and reference testing. Comparable in test menu and physician-referral channels, though primarily positioned as a specialty/reference lab rather than a multi-site walk-in network.

TypeBroad incumbent
Description

Major French independent laboratory network operating regional multi-site biology platforms. Directly comparable as a regional multi-site group offering routine analyses, reproductive biology, and physician referral services.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration6 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries24 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Novelab

Medical Laboratory Servicesnovelab.fr

Novelab is a French multi-site medical biology laboratory group operating 24 walk-in laboratory sites across the Lyon periphery, Ain, and Mâconnais regions, serving individual patients, referring physicians, clinics, and nursing homes with NABM-reimbursed analyses, specialized reproductive biology, and out-of-pocket screening panels under ISO 15189 V2022 quality standards.

What Novelab does

Novelab is a France-based multi-site medical biology laboratory group operating 24 physical laboratory sites across the Lyon periphery, the Ain department, and the Mâconnais region in southeast France. Founded in its current form in 2011 through the fusion of several legacy entities (dating back to 2005), the group is structured as a SELAS (Société d'Exercice Libéral par Actions Simplifiée) and is collectively owned by independent liberal biologists — both physicians and pharmacists — affiliated with the Groupement des Laboratoires de Biologie Indépendante (LBI). Novelab employs 150+ staff including biologists, qualified technicians, nurses, couriers, and support personnel, and conducts the vast majority of routine medical biology analyses in-house, outsourcing approximately 2% of specialized volume to Eurofins-Biomnis and the Établissement Français du Sang (EFS).

The group's service portfolio is anchored by routine NABM-reimbursed analyses (blood draws, urine tests, screenings) under the French Sécurité Sociale framework, complemented by specialized reproductive biology services (spermogram, TMS, spermoculture, MAR test, IAC/IUU intrauterine insemination) at three PMA-approved sites, as well as PCR COVID testing and a growing catalog of out-of-pocket sans-ordonnance panels (check-up €50, metabolic €45, fatigue €60, hormonal €42, STI panel). Technology infrastructure centers on ISO 15189 V2022 quality management, the MyKali secure online results portal, Doctolib appointment booking for specialized tests, and Identité Nationale de Santé (INS) identity verification, with ongoing lab-process automation investments such as the Beckman DxA chain at the Grand Laboratoire d'Ambérieu.

Commercially, Novelab pursues a hybrid direct-to-consumer and sales-led GTM: patients walk in without appointment at most sites Monday through Saturday, while a parallel referral-driven channel pulls volume from prescribing physicians, gynecologists, polyclinics, nursing homes, and liberal nurses operating in the territory. Recent geographic expansion (Charvieu-Chavagneux September 2025, Saint-Maurice-de-Beynost February 2026) and a sustained M&A track record (eight acquisitions or fusions since 2012) demonstrate a controlled roll-up strategy, while growing participation in CPTS (Communautés Professionnelles Territoriales de Santé) and urgent-care health centers signals increasing integration into the regional primary-care ecosystem.

Novelab firmographics

Firmographics
Name
Novelab
Legal name
NOVELAB S.E.L.A.S.
Website
https://novelab.fr
Company type
Private
Founded year
2011
Operating status
Operating
Headcount range
101–250 employees
Short description
Novelab is a French multi-site medical biology laboratory group operating 24 walk-in laboratory sites across the Lyon periphery, Ain, and Mâconnais regions, serving individual patients, referring physicians, clinics, and nursing homes with NABM-reimbursed analyses, specialized reproductive biology, and out-of-pocket screening panels under ISO 15189 V2022 quality standards.
Ownership category
akta.pro rank

Novelab industry classification

Industry
Product category
Medical Laboratory Services
NAICS
Medical and Diagnostic Laboratories (6215), Medical Laboratories (621511)
SIC
Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLAFAMAB
Clinical Chemistry & Immunoassay Laboratories

Keywords

  • Medical biology laboratory
  • Diagnostic testing services
  • Clinical pathology analysis
  • Reproductive biology services
  • Health screening packages

Where Novelab is headquartered

Location

Headquarters

HQ city
Corcelles-en-beaujolais
HQ country
France
HQ region
Europe

Offices24 records

Markets served

Novelab business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

  1. Medical Biology Analyses (NABM Reimbursement): The majority of revenue is generated through reimbursable medical biology analyses billed under the Nomenclature des Actes de Biologie Médicale (NABM) to the French national health insurance (Sécurité Sociale). Prices are regulated and periodically reduced by the Assurance Maladie. Some analyses are classified hors nomenclature (HN) and charged additionally to the patient.
  2. Out-of-Pocket Tests (Sans Ordonnance): Novelab offers certain tests without a prescription at fixed patient-paid prices (e.g., check-up package €50, beta-HCG pregnancy test €20, glycemia €16, ECBU €20, metabolic panel €45, fatigue panel €60, hormonal panel €42). These are paid directly by patients.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goCheck-up package (Bilan Check-up)
Unit PricingPay-as-you-goBeta-HCG pregnancy test (sans ordonnance)
Unit PricingPay-as-you-goGlycemia (diabetes screening, sans ordonnance)
Unit PricingPay-as-you-goECBU - urinary infection screening (sans ordonnance)
Unit PricingPay-as-you-goMetabolic panel - diabetes and cardiovascular risk (sans ordonnance)
Unit PricingPay-as-you-goFatigue panel (sans ordonnance)
Unit PricingPay-as-you-goHormonal panel - menopause assessment (sans ordonnance)

Go-to-market motion2 records

Distribution channels4 records

Marketing channels4 records

Novelab product offering

Product offering

Core offering

Novelab operates 24 medical biology laboratories across the Lyon periphery, Ain, and M\u00e2connais regions of France, performing routine medical biology analyses (blood draws, urine tests, microbiology) primarily reimbursed through the French national health insurance under NABM. The group offers specialized reproductive biology services (spermogram, spermoculture, intrauterine insemination) at three dedicated sites, PCR COVID testing, and self-paid health check-up packages without prescription. Patients access services via walk-in (no appointment required for most blood draws), Doctolib online booking for specialized tests, and retrieve results via the MyKali online portal.

Product overview

Novelab is a multi-site medical biology laboratory group consisting of 24 laboratory sites across the Lyon periphery, Ain, and Mâcon regions. The company offers a unified platform of services anchored by routine medical biology analyses (blood tests, urine tests) performed across all sites, complemented by specialized reproductive biology services including spermogram/TMS and intrauterine insemination (IUU/IAC) at designated locations. Additional offerings include PCR COVID testing, IST screening, and various health check-up packages available without prescription. Patients access results through an online portal and can book appointments via Doctolib. Specialized analyses (2% of volume) are outsourced to partners EUROFINS-BIOMNIS and EFS.

Differentiator

Problem solved

Functional benefit

Products and services

  • Routine Medical Biology Analyses Comprehensive range of routine medical biology tests including blood draws, urine tests, and other analyses performed across all 24 Novelab laboratory sites. Available to patients both with and without physician prescription, with most tests reimbursed under the French NABM nomenclature.
  • Spermiology Services Specialized reproductive biology services including spermogram, test de migration-survie (TMS), spermoculture, MAR test, and sperm DNA fragmentation analysis, available by appointment at designated Novelab sites.
  • Intrauterine Insemination (IUI/IAC) Intrauterine insemination (IUU/IAC) with approved biologists for sperm analysis, preparation, and insemination support at dedicated Novelab sites. Up to 6 covered attempts available per French social security reimbursement rules.
  • Test Post Coital (TPC/Huhner) Post-coital cervical mucus test performed during the pre-ovulatory period to evaluate cervical mucus permeability to spermatozoa, available at three designated Novelab sites.
  • PCR COVID Testing COVID-19 PCR testing available with or without appointments depending on symptomatic status, with result reporting to the SIDEP national database, performed at multiple Novelab laboratory sites including Villefranche-sur-Sa\u00f4ne.
  • IST Screening (Mon Test IST) Comprehensive sexually transmitted infection screening package covering HIV, Hepatitis B, Hepatitis C, Syphilis, Chlamydia, and Gonorrhea, available without prescription and fully covered for under-26 patients under French social security.
  • Bilan Check-up (Complete Check-up Package) Full check-up screening panel priced at €50 covering complete blood count, ferritin, TSH, kidney function, electrolytes, liver enzymes, CRP, glycemia, full lipid profile, uric acid, calcium, and vitamin D, available without a prescription.
  • Bilan Fatigue (Fatigue Panel) Fatigue assessment panel including NFS, ferritin, glycemia, transaminases, CRP, electrolytes, vitamin D, folate B9, vitamin B12, calcium, and magnesium, priced at €60 without prescription.
  • Bilan M\u00e9tabolique (Metabolic/Diabetes-Cardiovascular Panel) Metabolic and cardiovascular risk screening covering glycemia, insulin/HOMA/QUICKI, lipid profile, uric acid, kidney function, and electrolytes, priced at €45 without prescription.
  • Bilan Hormonal (Menopause Hormonal Panel) Hormonal panel measuring FSH and estradiol for menopause assessment, priced at €42 without prescription.
  • ECBU (Cytobacteriological Urine Examination) Cytobacteriological examination of urine for diagnosing urinary tract infections, priced at €20 without prescription.
  • Beta-hCG Pregnancy Test Blood-based pregnancy testing via beta-hCG hormone dosage, priced at €20 without prescription.
  • MyKali Online Results Portal Patient-facing web portal for securely accessing test results online via email notification, providing permanent password access for 180 days for result retrieval.

Companies that use Novelab

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles2 records

Novelab technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration6 records

Feature3 records

Novelab partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered minor and core.

  • Colloquium en Calade - Reproductive Biology PartnersminorGTM or Marketing Partner · 17 November 2023Annual scientific colloquium on infertility held in the Beaujolais region. Partners include: Theradiag, IBSA France, Organon France, Eugin, Ferring Pharmaceuticals France, Merck, Theramex, Gedeon Richter France, Institut Marquès, Barcelona IVF, EFFIK. Novelab is a sponsoring partner.
  • Eurofins-BiomniscoreStrategic or Co-development PartnerEurofins-Biomnis is a specialized medical biology laboratory providing reference analyses not performed in-house. Novelab refers approximately 2% of its analysis volume to Eurofins-Biomnis for specialized testing.
  • EFS (Établissement Français du Sang)coreStrategic or Co-development PartnerThe French Blood Establishment provides specialized blood banking and transfusion-related analyses. Novelab partners with EFS for the 2% of specialized volume that requires external laboratory services.

Scale indicators5 records

Recent moves9 records

Expansion highlights6 records

Novelab competitors and assessment

Company assessment

Others

  • Doctolib: Not a lab but a critical ecosystem partner integrated by Novelab for online appointment booking. Listed as OTHERS because it is an enabling technology platform that channels patient demand to Novelab's specialized services rather than a direct lab competitor.

Broad incumbents

  • Unilabs: European diagnostics provider with French operations covering routine and specialty medical biology. Comparable as a multi-site medical laboratory serving physicians, clinics, and patients across regions of France.
  • Synlab: Major pan-European medical diagnostics provider with a significant French laboratory footprint. Comparable as a multi-site routine and specialized medical biology operator serving physicians, clinics, and patients across regional France.
  • Inovie: French medical biology network consolidating independent labs nationally. Closely comparable in business model (multi-site routine biology + specialty) and explicitly competes for the same independent-lab consolidation pipeline as Novelab.
  • Eurofins-Biomnis: Specialized reference laboratory partner to which Novelab outsources 2% of its volume. Directly comparable as a French medical biology testing provider, with a much broader specialty test menu and national footprint.
  • Cerba HealthCare: One of the largest French/European medical biology networks, offering routine and specialized lab services. Comparable as a multi-site laboratory group serving French clinicians, though at significantly larger scale and broader geographic reach than Novelab.
  • Laboratoire Pasteur-Cerba: Specialized French medical biology lab offering routine and reference testing. Comparable in test menu and physician-referral channels, though primarily positioned as a specialty/reference lab rather than a multi-site walk-in network.
  • Biogroup: Major French independent laboratory network operating regional multi-site biology platforms. Directly comparable as a regional multi-site group offering routine analyses, reproductive biology, and physician referral services.

Regional players

  • Centre de Biologie Médicale (CBM): Regional French medical biology laboratory network offering routine analyses with multi-site presence. Comparable as a French regional multi-site laboratory group with similar NABM-reimbursed business model, though not necessarily overlapping Novelab's Lyon/Ain/Mâconnais territory.

Direct peers

  • Laboratoire de Biologie Médicale (LBI Groupement): Umbrella organization of independent French medical biologists of which Novelab is a member. Comparable as a federation of independent regional lab groups adhering to similar operating, quality, and governance models.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Novelab social profiles

Digital presence

Novelab compliance and trust

Trust signal

Compliance3 records

Novelab financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Novelab leadership team

Management profile

Number of profiles

Profiles3 records

Novelab subsidiaries and ownership

Company hierarchy

Subsidiaries24 records

Novelab funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Novelab M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Novelab

What does Novelab do?

Novelab operates 24 medical biology laboratories across the Lyon periphery, Ain, and M\u00e2connais regions of France, performing routine medical biology analyses (blood draws, urine tests, microbiology) primarily reimbursed through the French national health insurance under NABM. The group offers specialized reproductive biology services (spermogram, spermoculture, intrauterine insemination) at three dedicated sites, PCR COVID testing, and self-paid health check-up packages without prescription. Patients access services via walk-in (no appointment required for most blood draws), Doctolib online booking for specialized tests, and retrieve results via the MyKali online portal.

Is Novelab a public or private company?

Novelab is a private company. It is classified as management employee owned and is currently operating.

When was Novelab founded?

Novelab was founded in 2011. It employs 101 to 250 people.

Where is Novelab based?

Novelab is headquartered in Corcelles-en-beaujolais, France, in the Europe region.

How does Novelab make money?

Two revenue lines are on record. Medical Biology Analyses (NABM Reimbursement) is the primary driver. The others are out-of-Pocket Tests (Sans Ordonnance).

Who are Novelab's main competitors?

Doctolib is listed as an others. Broad incumbents are Unilabs, Synlab, Inovie, Eurofins-Biomnis, Cerba HealthCare, Laboratoire Pasteur-Cerba and Biogroup. Centre de Biologie Médicale (CBM) is listed as a regional player. Laboratoire de Biologie Médicale (LBI Groupement) is listed as a direct peer.

Does Novelab have an API?

No public API is recorded for Novelab.

What industry is Novelab in?

Novelab's product category is Medical Laboratory Services. Its primary akta.pro industry code is HLAFAMAB, Clinical Chemistry & Immunoassay Laboratories. Its NAICS code is 6215 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales